2-[(4-(癸氧基)苯氧基)甲基]环氧乙烷 | 408501-42-8

• 分子结构分类: 有机化合物 - 苯类化合物 - 苯酚醚
• 中文名称: 2-[(4-(癸氧基)苯氧基)甲基]环氧乙烷
• 英文名称: 2-[(4-(decyloxy)phenoxy)methyl]oxirane
• 英文别名: 2-(4-decyloxyphenoxymethyl)oxirane；2-[(4-Decoxyphenoxy)methyl]oxirane
• CAS: 408501-42-8
• 化学式: C₁₉H₃₀O₃
• 分子量: 306.445
• InChiKey: XKPBVGVMJPOLRG-UHFFFAOYSA-N

物化性质

• 熔点：
  57-58 °C
• 沸点：
  417.9±15.0 °C(Predicted)
• 密度：
  1.000±0.06 g/cm3(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  6.2
• 重原子数：
  22
• 可旋转键数：
  13
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.68
• 拓扑面积：
  31
• 氢给体数：
  0
• 氢受体数：
  3

反应信息

• 作为反应物：
  描述：

  2-[(4-(癸氧基)苯氧基)甲基]环氧乙烷 在 乙酸酐 、 sodium hydride 、 二甲基亚砜 作用下， 以 N,N-二甲基甲酰胺 为溶剂， 生成 Tert-butyl-1-[3-(4-decyloxyphenoxy)-2-oxopropyl]indole-5-carboxylate
  参考文献：
  名称：

  Design and Synthesis of 1-Indol-1-yl-propan-2-ones as Inhibitors of Human Cytosolic Phospholipase A₂α

  摘要：

  The synthesis and structure-activity relationship study of a series of 1-indol-1-yl-3-phenoxypropan-2-one inhibitors of cytosolic phospholipase A(2)alpha (cPLA(2)alpha) are described. The compounds were evaluated in a vesicle assay with isolated cPLA(2)alpha and in cellular assays with intact human platelets. Systematic variation led to 3-methylhydrogen 1-[3-(4-decyloxyphenoxy)-2-oxopropyl]indole-3,5-dicarboxylate (57), which revealed the highest activity against the isolated enzyme. With an IC50 value of 4.3 nM in this assay, it is one of the most potent in vitro cPLA(2)alpha inhibitors known today.

  DOI：

  10.1021/jm051243a
• 作为产物：
  描述：

  癸基溴 在 sodium hydride 、 caesium carbonate 作用下， 以 N,N-二甲基甲酰胺 、 乙腈 为溶剂， 反应 6.33h， 生成 2-[(4-(癸氧基)苯氧基)甲基]环氧乙烷
  参考文献：
  名称：

  Design and Synthesis of a Novel and Potent Series of Inhibitors of Cytosolic Phospholipase A₂ Based on a 1,3-Disubstituted Propan-2-one Skeleton

  摘要：

  Using knowledge of the substrate specificity of cPLA(2) (phospliolipases A(2)), a novel series of inhibitors of this enzyme were designed based upon a three point model of inhibitor binding to the enzyme active site comprising a lipophilic anchor, an electrophilic serine "trap", and an acidic binding moiety. The resulting 1,3-diheteroatom-substituted propan-2-ones were evaluated as inhibitors of cPLA2 in both aggregated bilayer and soluble substrate assays. Systematic variation of the lipophilic, electrophilic, and acidic groups revealed a well-defined structure-activity relationship against the enzyme. Optimization of each group led to compound 22 (ARC70484XX), which contains a decyloxy lipophilic side chain, a 1,3-diaryloxypropan-2-one moiety as a unique serine trap, and a benzoic acid as the acidic binding group. AR-C70484XX was found to be among the most potent in vitro inhibitors of cPLA2, described to date being more than 20-fold more active against the isolated enzyme (IC50 = 0.03 muM) than the standard CPLA(2) inhibitor, arachidonyl trifluoromethyl ketone (AACOCF(3)), and also greater than 10-fold more active than AACOCF3 against the cellular production of arachidonic acid by HL60 cells (IC50 = 2.8 muM).

  DOI：

  10.1021/jm011050x

文献信息

• [DE] NEUE HETEROARYLSUBSTITUIERTE ACETONDERIVATE ALS HEMMSTOFFE DER PHOSPHOLIPASE A2<br/>[EN] NOVEL HETEROARYL-SUBSTITUTED ACETONE DERIVATIVES AS INHIBITORS OF PHOSPHOLIPASE A2<br/>[FR] NOUVEAUX DERIVES D'ACETONE A SUBSTITUTION HETEROARYLE SERVANT D'INHIBITEURS DE PHOSPHOLIPASE A2
  申请人：MERCKLE GMBH

  公开号：WO2004069797A1

  公开（公告）日：2004-08-19

  Die Erfindung betrifft neuartige Heteroaryl-substituierte Acetonderivate welche das Enzym Phospholipase A2 hemmen, pharmazeutische Mittel, die diese Verbindungen enthalten und ein Verfahren zur Herstellung dieser Verbindungen.

  这项发明涉及新型杂环芳基取代的乙酰衍生物，可以抑制磷脂酶A2酶，包含这些化合物的制药物以及制备这些化合物的方法。
• Novel heteroaryl-substituted acetone derivatives as inhibitors of phospholipase a2
  申请人：Lehr Matthias

  公开号：US20060142366A1

  公开（公告）日：2006-06-29

  The invention relates to novel heteroaryl substituted acetone derivatives which inhibit the enzyme phospholipase A 2 , pharmaceutical preparations containing these compounds and a method of producing these compounds.

  本发明涉及新型杂环取代丙酮衍生物，其抑制磷脂酶A2酶，包含这些化合物的药物制剂以及制备这些化合物的方法。
• NEUE HETEROARYLSUBSTITUIERTE ACETONDERIVATE ALS HEMMSTOFFE DER PHOSPHOLIPASE A sb 2 /sb
  申请人：MERCKLE GMBH

  公开号：EP1590324A1

  公开（公告）日：2005-11-02
• US7608633B2
  申请人：——

  公开号：US7608633B2

  公开（公告）日：2009-10-27
• Design and Synthesis of a Novel and Potent Series of Inhibitors of Cytosolic Phospholipase A₂ Based on a 1,3-Disubstituted Propan-2-one Skeleton
  作者：Stephen Connolly、Colin Bennion、Sarah Botterell、Pamela J. Croshaw、Catherine Hallam、Kim Hardy、Paul Hartopp、Clive G. Jackson、Sarah J. King、Louise Lawrence、Antonio Mete、David Murray、David H. Robinson、Gillian M. Smith、Linda Stein、Iain Walters、Edward Wells、W. John Withnall

  DOI：10.1021/jm011050x

  日期：2002.3.1

  Using knowledge of the substrate specificity of cPLA(2) (phospliolipases A(2)), a novel series of inhibitors of this enzyme were designed based upon a three point model of inhibitor binding to the enzyme active site comprising a lipophilic anchor, an electrophilic serine "trap", and an acidic binding moiety. The resulting 1,3-diheteroatom-substituted propan-2-ones were evaluated as inhibitors of cPLA2 in both aggregated bilayer and soluble substrate assays. Systematic variation of the lipophilic, electrophilic, and acidic groups revealed a well-defined structure-activity relationship against the enzyme. Optimization of each group led to compound 22 (ARC70484XX), which contains a decyloxy lipophilic side chain, a 1,3-diaryloxypropan-2-one moiety as a unique serine trap, and a benzoic acid as the acidic binding group. AR-C70484XX was found to be among the most potent in vitro inhibitors of cPLA2, described to date being more than 20-fold more active against the isolated enzyme (IC50 = 0.03 muM) than the standard CPLA(2) inhibitor, arachidonyl trifluoromethyl ketone (AACOCF(3)), and also greater than 10-fold more active than AACOCF3 against the cellular production of arachidonic acid by HL60 cells (IC50 = 2.8 muM).